Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VETMULIN 10% PREMIX - Health Canada Drug Approval Details

Approvals/Health Canada/VETMULIN 10% PREMIX

Authorized

STANDARD

VETMULIN 10% PREMIX

KHYUVEFARMA, PREDSTAVITELSTVO🇨🇦 Health Canada

Approval Date: Feb 5, 2026
Approval ID: b15e477db2bfde73
Company: KHYUVEFARMA, PREDSTAVITELSTVO
Type: Standard

Approval Details

Approval Id: b15e477db2bfde73
Drug Approval Canada Name: VETMULIN 10% PREMIX
Product Name: VETMULIN 10% PREMIX
Status: Marketed
Status Date: 2021-06-02
Original Market Date: 2021-06-02
Drug Class: Veterinary
Dosage Form: Drug Premix
Route Of Administration: Oral
Schedule: Prescription
Atc Original: Not Applicable
Aig Number: 0128684008
Company Name: KHYUVEFARMA, PREDSTAVITELSTVO
Company Address: 5th Floor, 3a Nikolay Haytov Str Sofia Sofia Bulgaria 1113
Company Detail Path: /organization/khyuvefarma-predstavitelstvo

Company Information

Pharmaceutical Company Name: KHYUVEFARMA, PREDSTAVITELSTVO
Country Name: Russia
Province Name: Moscow
City Name: moscow,moscow,country_ru
Address: proezd Roshchinski 4-i 19

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Feb 5, 2026

Approval ID

b15e477db2bfde73

Type

Standard

Back to Health Canada Approvals